Boston Institute of Biotechnology (BIB) is a leading Contract Development and Manufacturing Organisation (CDMO) dedicated to providing comprehensive services to the pharmaceutical industry. With a team of visionary founders and core executives boasting an average of over 20 years of industrial experience each, BIB has successfully executed over 162 projects in biopharmaceutical manufacturing across research and development, production, and operations within globally-regulated markets. The company is committed to innovation, employing the advanced PanFlex-Engineering system, which facilitates the construction of biopharmaceutical production sites tailored to client needs. BIB operates an R&D facility situated outside of Boston and a cGMP facility near Shanghai.

Services include:
– Biologics
– Cell and Gene Therapy
– Drug Substance Manufacturing (API)
– Drug Product Formulation (FDF)
– Research & Development
– Clinical Trial Materials
– Packaging
– Regulatory Services
– Analytical Methods Development
– Protein and Peptide
– Injectables
– Analytical Services
– Contract Development and Manufacturing (CDMO)

Boston Institute of Biotechnology is well-equipped to support the evolving needs of the pharmaceutical sector, ensuring a high standard of service and compliance. For further information, please visit bostonbib.com.